Why is Vaishali Pharma falling/rising?

As of 19-Sep, Vaishali Pharma Ltd is experiencing a decline in its stock price, currently at 12.11, reflecting a change of -0.13 or -1.06%. The stock has underperformed its sector today by -1.33%. In terms of returns, over the past week, the stock has increased by 1.25%, but it has seen a significant drop of -3.74% over the past month and a staggering -30.76% year-to-date. The company has also reported weak long-term fundamental strength, with a -145.73% CAGR growth in operating profits over the last five years and a poor EBIT to Interest ratio of 1.68, indicating challenges in servicing its debt. Furthermore, the stock's profitability is low, as evidenced by an average Return on Equity of 7.89%. The recent quarterly results showed a decline in PAT by -24.7%, contributing to the stock's negative sentiment.
In the broader market context, while the Sensex has gained 0.85% over the past week, Vaishali Pharma's performance has been notably weaker, highlighting its struggles relative to the benchmark. The stock's liquidity remains adequate for trading, but a significant drop in delivery volume by -49.81% against the 5-day average suggests a lack of investor interest. Additionally, the stock has underperformed the BSE500 over various time frames, including the last three years and one year, further emphasizing its below-par performance in both the long and near term. Overall, these factors contribute to the stock's downward trajectory.